Literature DB >> 24648918

Elevated serum levels of vascular endothelial growth factor is effective as a marker for malnutrition and inflammation in patients with ovarian cancer.

Takafumi Watanabe1, Masahiko Shibata2, Hiroshi Nishiyama1, Shu Soeda1, Shigenori Furukawa1, Kenji Gonda3, Seiichi Takenoshita4, Keiya Fujimori1.   

Abstract

Vascular endothelial growth factor (VEGF) reportedly plays an important role in the progression of malignant neoplasms. In the present study, measured serum concentrations of VEGF were measured in patients with ovarian cancer and correlations with nutritional damage and chronic inflammation were analyzed. A significant increase in serum levels in patients compared to healthy volunteers was observed. Levels of VEGF were inversely correlated with serum concentrations of prealbumin, transferrin and retinol-binding protein. VEGF levels were also correlated with serum levels of c-reactive protein (CRP), an effective marker of inflammation. CRP levels were significantly elevated in patients with stage III and IV disease and inversely correlated with serum concentrations of total protein, prealbumin, transferrin and retinol-binding protein. These results demonstrated that an increased production of VEGF correlated with nutritional impairment and inflammation.

Entities:  

Keywords:  cachexia; nutritional damage; ovarian cancer; vascular endothelial growth factor

Year:  2013        PMID: 24648918      PMCID: PMC3916972          DOI: 10.3892/br.2013.54

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  22 in total

Review 1.  Systemic inflammation, cachexia and prognosis in patients with cancer.

Authors:  Christopher Deans; Stephen J Wigmore
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-05       Impact factor: 4.294

2.  Mortality risk scales in esophagectomy for cancer: their usefulness in preoperative patient selection.

Authors:  Lourdes Sanz; Victor J Ovejero; Juan J González; Carlos A Laso; Enedina Azcano; Francisco Navarrete; Enrique Martínez
Journal:  Hepatogastroenterology       Date:  2006 Nov-Dec

3.  Serum albumin as a significant prognostic factor for patients with gastric carcinoma.

Authors:  Luis F Oñate-Ocaña; Vincenzo Aiello-Crocifoglio; Dolores Gallardo-Rincón; Roberto Herrera-Goepfert; Rocío Brom-Valladares; José F Carrillo; Eduardo Cervera; Alejandro Mohar-Betancourt
Journal:  Ann Surg Oncol       Date:  2006-12-09       Impact factor: 5.344

Review 4.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

5.  Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.

Authors:  Hanbyoul Cho; Hye Won Hur; Sang Wun Kim; Sung Hoon Kim; Jae Hoon Kim; Young Tae Kim; Kook Lee
Journal:  Cancer Immunol Immunother       Date:  2008-04-15       Impact factor: 6.968

Review 6.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

7.  Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma.

Authors:  Wendy K Nevala; Celine M Vachon; Alexey A Leontovich; Christopher G Scott; Michael A Thompson; Svetomir N Markovic
Journal:  Clin Cancer Res       Date:  2009-02-24       Impact factor: 12.531

8.  Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progression.

Authors:  P Terheyden; D Schrama; L Ø Pedersen; M H Andersen; E Kämpgen; P thor Straten; J C Becker
Journal:  Scand J Immunol       Date:  2003-11       Impact factor: 3.487

9.  Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

Authors:  W Chua; K A Charles; V E Baracos; S J Clarke
Journal:  Br J Cancer       Date:  2011-03-29       Impact factor: 7.640

Review 10.  Progress and challenges in screening for early detection of ovarian cancer.

Authors:  Ian J Jacobs; Usha Menon
Journal:  Mol Cell Proteomics       Date:  2004-02-05       Impact factor: 5.911

View more
  5 in total

1.  Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma.

Authors:  Weijie Gu; Guiming Zhang; Lijiang Sun; Qi Ma; Yue Cheng; Hailiang Zhang; Guohai Shi; Yao Zhu; Dingwei Ye
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-20       Impact factor: 12.910

2.  Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer.

Authors:  Takafumi Watanabe; Masahiko Shibata; Hiroshi Nishiyama; Shu Soeda; Shigenori Furukawa; Kenji Gonda; Seiichi Takenoshita; Keiya Fujimori
Journal:  Oncol Lett       Date:  2013-12-06       Impact factor: 2.967

3.  Constructing an ovarian cancer metastasis index by dissecting medical records.

Authors:  Yanjun Qu; Yanan He; Zhangming Li; Xiuwei Chen; Qian Liu; Shuangshuang Zou; Congcong Kong; Yixiu Liu; Ce Gao; Guangmei Zhang; Wenliang Zhu
Journal:  Oncotarget       Date:  2017-11-06

4.  Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy.

Authors:  Mary Jo Fidler; Casey Frankenberger; Richard Seto; Gabriela C Lobato; Cristina L Fhied; Selina Sayidine; Sanjib Basu; Mark Pool; Reem Karmali; Marta Batus; Wen-Rong Lie; David Hayes; Jehangir Mistry; Philip Bonomi; Jeffrey A Borgia
Journal:  Oncotarget       Date:  2017-04-28

5.  Low serum prealbumin levels on admission can independently predict in-hospital adverse cardiac events in patients with acute coronary syndrome.

Authors:  Wei Wang; Chun-Song Wang; Dong Ren; Tai Li; Heng-Chen Yao; Sheng-Jun Ma
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.